Stock Code: 000999 stock abbreviation: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) No.: 2021-053
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999)
Announcement of estimated amount of daily connected transactions in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records
Misleading statements or material omissions.
1、 Basic information of the estimated amount of daily connected transactions in 2022
(i) Summary of estimated amount of daily related party transactions
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) (hereinafter referred to as “the company” or “the company”) convened the 14th meeting of the board of directors in 2021 on December 30, 2021 to consider the proposal on the estimated amount of daily connected transactions in 2022. The connected directors Mr. Han Yuewei, Mr. Wei Xing, Mr. Liu Xuhai and Mr. Yang Xudong avoided voting. The meeting was agreed by 6 votes and opposed by 0 votes, The proposal was considered and adopted with 0 abstention.
This related party transaction must be approved by the general meeting of shareholders, and the related shareholder China Resources Pharmaceutical Holdings Co., Ltd. will waive its voting right on the proposal at the general meeting of shareholders.
In order to ensure the stable operation of the company’s production and operation, the company and its subsidiaries expect that the total amount of daily related party transactions with related parties controlled by the same controller China Resources Co., Ltd. in 2022 will not exceed 2162.9013 million yuan. Among them, the company and its subsidiaries are expected to sell 171808080300 yuan of products and commodities to related parties, and the company and its subsidiaries are expected to purchase 444821000 yuan of products and commodities from related parties. From January to October 2021, the company and its subsidiaries sold products and commodities to related parties of RMB 1065088100, and the company and its subsidiaries purchased products and commodities from related parties of RMB 243107600 (note).
（2） Category and amount of estimated daily related party transactions
As of October 31, 2021, related party transactions, related party transactions, related party pricing, original estimated amount in 2022, amount of gold category (10000 yuan) (note)
The market price of products purchased from related parties, purchased products controlled by the common controller and suppliers is 44482.1024310.76
Enterprise subtotal of goods
The market price of products sold to related parties, products sold under the control of the joint controller and suppliers is 171808.03106508.81
Enterprise subtotal of goods
Total 216290.13130819.57
Specific estimates are as follows:
The original estimated amount of related party pricing in 2022 as of October 31, 2021, the amount of related party transactions of related parties (10000 yuan) (note)
The market price of products and commodities purchased by China Resources Pharmaceutical Group Co., Ltd. is 38127.8222379.39
Affiliated enterprises of the company
The market price of China Resources Gas Co., Ltd. and purchased energy is 1369.421088.98
Its subsidiaries
Purchase property from related parties, China Resources Land Co., Ltd. and
The market price of goods and their affiliated enterprises’ procurement services is 2558.86644.41
Runlian software system (Shenzhen)
The market price of procurement services of the company and its subsidiaries is 2167.5261.89
trade
The same final controller controls the market price of purchased products and suppliers 258.48136.09
Other enterprise products and services
Subtotal of purchasing from related persons 44482.1024310.76
China Resources Pharmaceutical Group Co., Ltd. sells products of affiliated enterprises of the company to related parties at the market price of 170736.16105609.68
The same final controller of products and commodities controls the sales of products and suppliers
Market price of other physical products 1071.87899.13
Subtotal of sales to related parties 171808.03106508.81
Total 216290.13130819.57
Among them, the transaction amount with a single related party is expected to be more than 3 million and reach the audited value of the listed company in the previous year
The details of 0.5% of net assets are as follows:
Related party transaction category related party transaction content estimated amount in 2022 (10000 yen as of October 31, 2021) amount incurred (10000 yuan) (note)
Purchase products, commodities 29016.8916793.31 products and commodities from related parties of Quzhou Nankong traditional Chinese Medicine Co., Ltd
Sales of products and commodities sold by China Resources Hunan Pharmaceutical Co., Ltd. to related parties 36756.6325413.23 products and commodities
Products and commodities sold by China Resources Henan Pharmaceutical Co., Ltd. 17755.1111161.95
Products and commodities sold by China Resources Jiangsu Pharmaceutical Co., Ltd. 12746.148504.00
China Resources Hubei pharmaceutical Co., Ltd. sells products and commodities at 12499.988497.97
China Resources Pharmaceutical Commercial Group Co., Ltd. sells products and commodities 12241.817276.19
Products and commodities sold by China Resources Shandong Pharmaceutical Co., Ltd. 10548.377776.32
China Resources Xinlong (Shanxi) pharmaceutical has sales products and commodities 9127.125846.35 Co., Ltd
Note: as of October 31, 2021, the amount and other data have not been audited, and the actual data of the amount in 2021 shall be subject to the final audit result.
The controlling shareholder of the company is China Resources Pharmaceutical Holdings Co., Ltd. (hereinafter referred to as “China Resources Pharmaceutical Holdings”), and the actual controller is China Resources Co., Ltd. The counterparties of daily connected transactions expected by the company are enterprises controlled by the same controlling party, China Resources Co., Ltd. Due to the large number of connected persons, the estimated transactions with small single amount are consolidated and listed according to the same actual controller.
（3） Actual occurrence of daily connected transactions from January to October 2021
As of 2021
As of October 31, 2021
Index of the difference between the amount of related transactions and related parties’ related transactions as of October 31 (add the actual amount on October 31 and the amount of easy content (after 10000) on the disclosure date and category of the whole year) and the expected amount
(yuan) difference between similar businesses (%)
Proportion (%)
Purchase products jointly controlled by related persons 24310.7631960.552.25% – 23.94% of products and commodities controlled by the purchase party on January 30, 2021, subtotal of products and commodities enterprises in December 2021
Subtotal (No.) of products and commodities announced on www.info.com 106508.81126130.748.14% – 15.56% of products and commodities controlled by the manufacturer are sold to related parties on the tide of sales production month 14
2021-003, total 130819.57158091.29 — 17.25% (2021-050)
The board of directors of the company is actually responsible for the daily related party transactions
The occurrence is quite different from the expected situation-
Description (if applicable)
The independent directors of the company are responsible for the daily related party transactions
There is a big difference between the international occurrence and the prediction-
Description of (if applicable)
Specific estimates are as follows:
Up to 2021 up to 2021 up to 2021 related party transactions
